Drug
Baffr Car T Cells
Baffr Car T Cells: highest development phase Phase 1, developed by PeproMene Bio, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- PeproMene Bio, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| BAFFR-CAR T cells NCT05370430 | Phase 1 | Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma |
Latest
No recent events.
Follow Baffr Car T Cells on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.